Purification of immunomodulatory factors in human peripheral blood leukocytes

Influence of a DLE-extracted lymphocytic suppressor factor on CsA-induced immunosuppression

From dialyzable leucocyte extracts (DLE) we have purified a hydrophilic low-mol. wt. factor (about 1 kDa) which we have named lymphocytic suppressor factor (LSF) as it is able to suppress antigen- and mitogen-induced lymphocyte transformation and to prolong allograft survival in C57b/6N mice (H-2b) transplanted with fully mismatched skin from C3H/HeN mice (H-2k). At the molecular level LSF acts by inhibiting DNA replicational and transcriptional processes in activated lymphocytes, isolated rat hepatocyte nuclei, and cell-free systems. Amino acid analysis indicates that LSF is a peptide composed of Asp, Glu, Ser, Thr, Ala, Gly, Arg and probably Met, with the N-terminus blocked, possibly by pyroglutamic acid. When combined "in vitro" with cyclosporine A (CsA), LSF increased about 20 times the potency of CsA in inducing suppression of mitogen-stimulated lymphocytes. In C57b/6N mice with skin graft from C3H/HeN mice and undergoing immunosuppression with CsA (50 mg/kg/day), the splenocyte LSF content increased about 5 times. However, LSF values returned to normal in mice recovering normal responsiveness due to progressive withdrawal of CsA. These data show that LSF has an important role in the development and maintenance of CsA-induced immunosuppression. We suggest that, by influencing DNA replicational and transcriptional processes of lymphocytes, LSF may play a role also in the onset and progression of AIDS induced by retroviruses.

Bovine seminal plasma contains factors that enhance lymphocyte transformation in vitro

The important immunosuppressive properties of seminal plasma have significant functions in the processes of reproduction. They mask the presence of an immunostimulating activity. From bovine seminal plasma two active factors have been isolated and characterized with marked enhancing activity for in vitro PHA-dependent lymphocyte transformation. They have inosine and hypoxanthine structures, as confirmed by UV absorption profiles, TLC, mass spectrometry, HPLC patterns, behavior to enzymatic treatments, and breaking of purine ring after acid treatment. Nevertheless, their biological activities are about two orders of magnitude higher than those of commercially available inosine and hypoxanthine standards. Biological activities became practically identical when these were processed (HPLC) in the same way as native molecules. A study to explain such a discrepancy is in progress.